BEAM: a randomized phase II study evaluating the activity of bevacizumab in combination with carboplatin plus paclitaxel in patients with previously untreated advanced melanoma.

Kim KB, Sosman JA, Fruehauf JP, Linette GP, Markovic SN, McDermott DF, Weber JS, Nguyen H, Cheverton P, Chen D, Peterson AC, Carson WE, O'Day SJ
J Clin Oncol. 2012 30 (1): 34-41

PMID: 22124101 · PMCID: PMC4669379 · DOI:10.1200/JCO.2011.34.6270

MeSH Terms (20)

Adult Aged Aged, 80 and over Angiogenesis Inhibitors Antibodies, Monoclonal, Humanized Antineoplastic Combined Chemotherapy Protocols Bevacizumab Carboplatin Double-Blind Method Drug Administration Schedule Female Humans Infusions, Intravenous Kaplan-Meier Estimate Male Melanoma Middle Aged Paclitaxel Skin Neoplasms Treatment Outcome

Connections (1)

This publication is referenced by other Labnodes entities: